Grupo para la caracterización molecular de las neoplasias hematológicas
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milán, ItaliaPublicaciones en colaboración con investigadores/as de Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (4)
2023
-
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The Lancet, Vol. 401, Núm. 10373, pp. 269-280
-
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 1, pp. 279-288
2021
-
Cereblon enhancer methylation and IMiD resistance in multiple myeloma
Blood, Vol. 138, Núm. 18, pp. 1721-1726
-
Pathogenetic and prognostic implications of increased mitochondrial content in multiple myeloma
Cancers, Vol. 13, Núm. 13